Birchview Capital, LP Portfolio Holdings

Birchview Capital, LP

  • $108 Million
  • Q3 2024

Birchview Capital, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $108 Million distributed in 62 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $35.5M, Biodesix Inc with a value of $9.86M, Acadia Pharmaceuticals Inc with a value of $6.16M, United Therapeutics Corp with a value of $3.58M, and Prothena Corp Public LTD CO with a value of $3.51M.

Examining the 13F form we can see an increase of $8.32M in the current position value, from $100M to 108M.

Birchview Capital, LP is based out at Burlington, VT

Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $108 Million
Healthcare: $105 Million
Energy: $3.27 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$127B
$35.5 Million 32.76% of portfolio
686,182
Q3 2024 Reduced 0.3%
$41.2M
$9.86 Million 9.1% of portfolio
5,541,176
Q2 2024 Added 6.7%
$3B
$6.16 Million 5.68% of portfolio
400,400
Q3 2024 Added 59.9%
$16.1B
$3.58 Million 3.31% of portfolio
10,000
Q2 2024 Reduced 9.09%
$631M
$3.51 Million 3.23% of portfolio
209,574
Q3 2024 Added 2.95%
$14.4B
$3.48 Million 3.21% of portfolio
30,240
Q3 2024 Reduced 28.41%
$7.13B
$3.42 Million 3.16% of portfolio
74,000
Q2 2024 Added 48.0%
$807M
$3.28 Million 3.02% of portfolio
72,910
Q3 2024 Reduced 51.39%
$166M
$2.99 Million 2.76% of portfolio
320,930
Q1 2024 Added 21.18%
$758M
$2.76 Million 2.55% of portfolio
197,000
Q2 2024 Added 13.87%
$1.48B
$2.61 Million 2.41% of portfolio
114,700
Q1 2024 Added 38.69%
$454M
$2.58 Million 2.38% of portfolio
210,000
Q1 2024 Added 147.06%
$1.83B
$2.16 Million 1.99% of portfolio
48,000
Q1 2024 Added 26.32%
$1.3B
$2.07 Million 1.91% of portfolio
148,000
Q3 2024 Added 21.31%
$9.04B
$2.04 Million 1.88% of portfolio
15,280
Q2 2022 Added 64.66%
$10.7B
$2 Million 1.84% of portfolio
52,200
Q3 2024 Reduced 29.65%
$480M
$1.71 Million 1.58% of portfolio
515,000
Q3 2024 Added 11.96%
$756M
$1.65 Million 1.53% of portfolio
58,000
Q3 2024 Added 70.59%
$5.05B
$1.4 Million 1.29% of portfolio
50,000
Q2 2021 Added 42.86%
$19.2B
$1.27 Million 1.17% of portfolio
34,619
Q3 2024 New
$1.2B
$1.1 Million 1.02% of portfolio
198,000
Q3 2024 Added 125.0%
$227M
$949,000 0.88% of portfolio
82,000
Q3 2024 Added 78.26%
$651M
$749,000 0.69% of portfolio
30,000
Q3 2021 Added 50.0%
$1.37B
$677,000 0.62% of portfolio
30,000
Q1 2024 Added 42.86%
$7.84B
$572,000 0.53% of portfolio
10,000
Q4 2022 New
$133M
$556,000 0.51% of portfolio
325,239
Q1 2024 Added 44.4%
$4.56B
$528,000 0.49% of portfolio
10,000
Q1 2024 Reduced 60.0%
$287M
$406,000 0.37% of portfolio
7,000
Q4 2022 New
$537M
$396,000 0.37% of portfolio
68,350
Q3 2024 New
$3.13B
$403,000 0.37% of portfolio
14,000
Q2 2024 Reduced 22.22%
$2.46B
$393,000 0.36% of portfolio
10,000
Q2 2022 New
$86.3M
$386,000 0.36% of portfolio
372,000
Q3 2024 Added 37.78%
$49.5M
$389,000 0.36% of portfolio
469,832
Q1 2024 Reduced 17.84%
$910M
$369,000 0.34% of portfolio
15,000
Q1 2020 Reduced 50.0%
$2.17B
$368,000 0.34% of portfolio
22,000
Q1 2024 Added 22.22%
$2.7B
$368,000 0.34% of portfolio
7,365
Q1 2024 New
$4.61B
$359,000 0.33% of portfolio
4,000
Q1 2024 New
$459M
$334,000 0.31% of portfolio
20,000
Q2 2024 Reduced 20.36%
$2.24B
$320,000 0.3% of portfolio
10,000
Q1 2024 New
$1.03B
$328,000 0.3% of portfolio
40,000
Q1 2024 New
$2.49B
$312,000 0.29% of portfolio
20,000
Q2 2024 New
$9.97B
$312,000 0.29% of portfolio
2,500
Q3 2022 New
$2.7B
$299,000 0.28% of portfolio
28,000
Q4 2022 Reduced 26.32%
$1.42B
$304,000 0.28% of portfolio
40,000
Q2 2024 Added 100.0%
$6.66B
$249,000 0.23% of portfolio
2,700
Q3 2024 New
$1.05B
$247,000 0.23% of portfolio
12,300
Q3 2017 New
$96.8M
$136,000 0.13% of portfolio
138,176
Q1 2024 Reduced 33.91%
$542M
$109,000 0.1% of portfolio
211,200
Q3 2024 Reduced 32.13%
$736M
$98,000 0.09% of portfolio
20,000
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 62
  • Current Value $108 Million
  • Prior Value $100 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 5 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email